The NLSDays Super Session about “What’s hot in the eyes of international investors?” brought up the importance about having solid science, new and innovative technology and being able to explain this.
Alison Hilton from the DNM emphasized the importance of proving yourself from a health economic standpoint and in terms of their interests and she said that they are starting more and more to work with China, India and Australia, as well as the fields of diagnostics and lab services.
The panel also talked about crowdfunding and the issues of dealing with different shareholders, and Andreas Lindblom from Sciety explained that they have found ways to deal with issues that may come up when several shareholders are involved..
Nina Rawal from Industrifonden adviced companies to not go public too early, build on academic competence and include a health economic perspective. She mentioned oncology and digital health as areas of interest in the future.
In conclusion, do your homework about the investors within your space, understand their interests and requirements and communicate your message clearly and last but not least, provide good science and good data.